Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Two exergame-based cognitive-motor rehabilitation programs for people with Huntington's disease

Official title: CARE-MH: Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease Patients

Run by University Hospital, Angers · NCT06807892 · Data updated 2026-11-12

This research tests whether two different exergame-based programs can help thinking, movement, and behavior in adults with early-stage Huntington's disease.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity Hospital, Angers
Government
Locations1 site (Angers)
StatusRecruiting
StartedJuly 31, 2025
Main results expectedOctober 17, 2027
Study endsOctober 17, 2027
Registry record updatedMarch 17, 2026
Trial IDNCT06807892 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with genetically confirmed stage 1–2 Huntington's disease who meet the motor (UHDRS ≥ 5) and cognitive (CFT > 6 and ≤ 13) entry criteria, can give informed consent (or have third-party consent), and can understand French are the intended participants.

Probably not a fit

People with advanced disease, severe cognitive deficit (MMSE < 16), major psychiatric or neurological conditions that affect cognition, pregnant or breastfeeding women, or those who cannot understand French are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with genetically confirmed stage 1–2 Huntington's disease and specified motor and cognitive scores will be enrolled and receive one of two supervised cognitive-motor rehabilitation programs delivered via exergames (either a synergistic or a sequential approach). Interventions combine physical activity and cognitive stimulation through interactive game-like exercises adapted to motor and cognitive abilities. Outcomes will include standardized measures of motor function (including UHDRS motor items), cognitive tests, and behavioral scales collected before and after the intervention to compare effects between the two approaches. The protocol targets feasibility and preliminary clinical signals rather than claiming definitive therapeutic benefit.

Why it matters

Potential benefit: If successful, the programs could improve or stabilize motor, cognitive, and behavioral symptoms using accessible exergame-based rehabilitation.

How similar studies have gone: Exergame and combined physical-cognitive programs have shown encouraging results in Parkinson's disease, multiple sclerosis, and other conditions, but rigorous evidence specifically in Huntington's disease remains limited and preliminary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults at inclusion
* Huntington's disease diagnosed and confirmed by genetic analysis
* Patient with stage 1-2 HD with a motor UHDRS score ≥ 5 and a CFT between 6 \< CFT ≤ 13
* Patient with written informed consent or third-party consent
* Affiliated or beneficiary of a social security scheme

Exclusion Criteria:

* Poor understanding of the French language
* Participation in interventional research modifying management
* History likely to interfere with cognition (established stroke, sequelae of traumatic brain injury, active epilepsy, learning disorders, alcohol dependence syndrome, drug use, psychiatric disorders), severe cognitive deficit (MMSE \<16), clinically significant pathological condition which, in the investigator's opinion, could interfere with the subject's safety or the evaluation of study results
* Pregnant or breast-feeding women
* Persons deprived of their liberty by administrative or judicial decision
* Persons under compulsory psychiatric care

Where it's running

  • Angers University hospital
    Angers, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.